$0.00050
-0.15-99.68%
Last update: Oct 16, 11:34 AM
$0.0100
-0.14-93.5%
CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc.
CARMOTCEM
CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (CARM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | $-0.12 | $-0.10 | $-0.22 |
| Actual | $1.07 | $-0.23 | $-0.22 | $-0.42 |
| Surprise | +991.7% | -91.7% | -120.0% | -90.9% |
| Revenue | ||||
| Estimate | $3.8M | $3.8M | $2.5M | $5.4M |
| Actual | $45.3M | $0 | $3.7M | $3.7M |
| Surprise | +1100.0% | -100.0% | +51.0% | -32.6% |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 12, 2025 | $1.07 | $-0.12 | 991.7 % |
| Q2 | Aug 7, 2025 | $-0.23 | $-0.12 | -91.7 % |
| Q1 | May 13, 2025 | $-0.22 | $-0.10 | -120.0 % |
| Q4 | Mar 31, 2025 | $-0.42 | $-0.22 | -90.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 12, 2025 | $45.25M | $3.77M | 1100.0 % |
| Q2 | Aug 7, 2025 | $0 | $3.75M | -100.0 % |
| Q1 | May 13, 2025 | $3.73M | $2.47M | 51.0 % |
| Q4 | Mar 31, 2025 | $3.65M | $5.42M | -32.6 % |
